Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence

Cancer Research

Volumn 64, Issue 6, 2004, Pages 2212-2221

  Ettinger, Susan L ^a   Sobel, Richard ^a   Whitmore, Tanis G ^a   Akbari, Majid ^a   Bradley, Dawn R ^a   Gleave, Martin E ^a   Nelson, Colleen C ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A BINDING PROTEIN; ANDROGEN; BINDING PROTEIN; DIAZEPAM BINDING INHIBITOR; FARNESYL DIPHOSPHATE; FATTY ACID SYNTHASE; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CASTRATION; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; LIPOGENESIS; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANDROGENS; ANIMALS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIVISION; CHOLESTEROL; DISEASE PROGRESSION; DNA-BINDING PROTEINS; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOADJUVANT THERAPY; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROLS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 1542615071     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-2148-2     Document Type: Article

References (56)

1. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45.
2. Gleave ME, Hsieh JT, Gao CA, von Eschenbach AC, Chung LWK. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991;51:3753-61.
3. Gleave ME, Hsieh JT, von Eschenbach AC, Chung LWK. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional stromal-epithelial interaction in prostate cancer growth and metastasis. J Urol 1992; 147:1151-9.
4. Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC, Chung LWK. Serum prostate-specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 1992;52:1598-605.
5. Hsieh JT, Wu, H-C, Gleave ME, von Eschenbach AC, Chung LWK. Autocrine regulation of PSA gene expression in a human prostatic cancer (LNCaP) subline. Cancer Res 1993;53:2852-7.
6. Wu H-C, Hsieh JT, Gleave ME, Chung LWK. Derivation of androgen-independent human LNCaP prostate cancer cell lines: role of bone stromal cells. Int J Cancer 1994;57:406-12.
7. Gleave ME, Tolcher A, Miyake H, Beraldi E, Goldie J. Progression to androgen-independence is delayed by antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Clin Cancer Res 1999;5:2891-8.
8. Swinnen JV, Ulrix W, Heyns W, Verhoeven G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 1997;94:12975-80.
9. Yokoyama C, Wang X, Briggs MR, et al. SREBP-1, a basic helix-loop-helix leucine zipper protein that controls transcription of the LDL receptor gene. Cell 1993;75: 187-97.
10. Hua X, Yokoyama C, Wu J, et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 1993;90:11603-7.
11. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997;89:331-40.
12. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS. Hairpin orientation of sterol regulatory element binding protein-2 in cell membranes as determined by protease protection. J Biol Chem 1995;270:29422-7.
13. Duncan EA, Brown MS, Goldstein JL, Sakai J. Cleavage site for sterol-regulated protease localized to a Leu-Ser bond in lumenal loop of sterol regulatory element binding protein-2. J Biol Chem 1997;272:12778-85.
14. Sakai J, Nohturfft A, Goldstein JL, Brown MS. Cleavage of sterol regulatory element-binding proteins (SREBPS) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. J Biol Chem 1998;273:5785-93.
15. DeBose-Boyd RA, Brown MS, Li WP, et al. Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 1999;99:703-12.
16. Sakai J, Duncan EA, Rawson RB, et al. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 1996;85:1037-46.
17. Pai J-T, Brown MS, Goldstein JL. Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. Proc Natl Acad Sci USA 1996;93:5437-42.
18. Wang X, Zelenski NG, Yang J, et al. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 1996;15:1012-20.
19. Brown MS, Goldstein JL. Cleavage of sterol regulatory element-binding proteins (SREBPs) at a site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. Proc Natl Acad Sci USA 1999;96: 11041-8.
20. Wang X, Sato R, Brown MS, Hua X, Goldstein, LL. SREBP-1, a membrane bound transcription factor released by sterol-regulated proteolysis. Cell 1994;77:53-62.
21. Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol 1998;65:191-8.
22. Miyake H, Nelson C, Rennie P, Gleave ME. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol-3-kinase pathway. Endocrinology 2000;141:2257-65.
23. Heemers H, Maes B, Foufelle F, et al. Androgens stimulated lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 2001;15:1817-28.
24. Swinnen JV, Alen P, Heyns W, Verhoeven G. Identification of diazepam-binding inhibitor/acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene. J Biol Chem 1998;273:19938-44.
25. Swinnen JV, Esquenet M, Heyns W, Rombauts W, Verhoeven G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP. Mol Cell Endocrinol 1994;104:153-62.
26. Swinnen JV, Vercaeren I, Esquenet M, Heyns W, Verhoeven G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the rat. Mol Cell Endocrinol 1996;118:65-70.
27. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology 1996;137:4468-74.
28. Horton JD, Shimomuraa I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999;10:143-50.
29. Roth G, Kotzka J, Kremer L, et al. MAP kinases Erk1/2 phoshorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 2000;275: 33302-7.
30. Xiong S, Chirala SS, Wakil SJ. Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites. Proc Natl Acad Sci USA 2000;97:3948-53.
31. Shea-Eaton W, Lopez D, McLean MP. Yin yang 1 protein negatively regulates high-density lipoprotein receptor gene transcription by disrupting binding to sterol regulatory element binding protein to the sterol regulatory element. Endocrinology 2001;142:49-58.
32. Sundqvist A, Ericsson J. Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. Proc Natl Acad Sci USA 2003;100: 13833-8.
33. Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding protein. Proc Natl Acad Sci USA 2002;99:12753-8.
34. Sheng Z, Otani H, Brown MS, Goldstein LL. Independent regulation of sterol regulatory element binding proteins 1 and 2 in hamster liver. Proc Natl Acad Sci USA 1995;92:935-8.
35. Rasmussen JT, Rosendal J, Knudsen J. Interaction of acyl-CoA binding protein (ABCP) on processes for which acyl-CoA is a substrate, product or inhibitor. Biochem J 1993;292:907-13.
36. Rasmussen JT, Faergeman NJ, Kristiansen K, Knudsen J. Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for β-oxidation and glycerolipid synthesis. Biochem J 1994;299:165-70.
37. Mandrup S, Jepsen R, Skott H, et al. Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. Biochem J 1993;290: 369-74.
38. Papadopoulos V, Brown AS. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol 1995;53:103-10.
39. Papadopoulos V, Amri H, Boujrad N, et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 1997;62:21-8.
40. Papadopoulos V, Amri H, Li H, et al. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem 1997;272:32129-35.
41. Bono F, Lamarch I, Prabonnaud V, Le Fur G, Herbert JM. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun 1999;265:457-61.
42. Stoebner PE, Carayon P, Casellas P, et al. Transient protection by peripheral benzo-diazepine receptors during the early events of ultraviolet light-induced apoptosis. Cell Death Differ 2001;8:747-53.
43. Papadopoulos V, Dharmarajan MM, Li H, et al. Mitochondrial peripheral-type benzodiazepine receptor expression Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum Biochem Pharmacol 1999;58:1389-93.
44. Hardwick M, Fertikh D, Culty M, et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999;59:831-42.
45. Petrescu AD, Paynes HR, Boedecker A, et al. Physical and functional interaction of acyl-CoA-binding protein with hepatocyte nuclear factor-4α. J Biol Chem 2003;278: 51813-24.
46. Weiss L, Hoffmann GE, Schreiber R, et al. Fatty-acid biosynthesis in man: a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe-Seyler 1986;367:905-12.
47. Myers RB, Oelschlager DK, Weiss HL, Frost AR, Grizzle WE. Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen-independence. J Urol 2001;165:1027-32.
48. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in human prostate cancer cell line LNCaP. Cancer Res 1997;57: 1086-90.
49. Epstein JI, Carmichael M, Partin AW. OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate. Urology 1995;45:81-6.
50. Furuya Y, Akimoto S, Yasuda K, Ito H. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res 1997;17:4589-94.
51. Pizer ES, Pflug BR, Bova GS, et al. Increased fatty acid synthase as a therapeutic target in androgen independent prostate cancer progression. Prostate 2001;47: 102-10.
52. Pizer ES, Wood FD, Pasternack GR, Kuhajda FP. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL-60 promyelocytic leukemia cells. Cancer Res 1996;56:745-51.
53. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1998;58:4611-5.
54. Pizer ES, Thupari J, Han WF, et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2000;60:213-8.
55. Kuhajda FP, Pizer ES, Li JN, et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 2000;97:3450-4.
56. Chen Y, Hughes-Fulford M. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator SREBP2. Int J Cancer 2001;91:41-5.